Structure based design of iminohydantoin BACE1 inhibitors: Identification of an orally available, centrally active BACE1 inhibitorJared N. Cumming, Andrew W. Stamford, Ulrich Iserloh et al.|Bioorganic & Medicinal Chemistry Letters|2012Cited by 153
Discovery of Cyclic Acylguanidines as Highly Potent and Selective β-Site Amyloid Cleaving Enzyme (BACE) Inhibitors: Part I—Inhibitor Design and ValidationZhaoning Zhu, John C. Hunter, Reshma Kuvelkar et al.|Journal of Medicinal Chemistry|2009Cited by 121
Application of Fragment-Based NMR Screening, X-ray Crystallography, Structure-Based Design, and Focused Chemical Library Design to Identify Novel μM Leads for the Development of nM BACE-1 (β-Site APP Cleaving Enzyme 1) InhibitorsYu‐Sen Wang, Daniel F. Wyss, Brian A. McKittrick et al.|Journal of Medicinal Chemistry|2009Cited by 102
Cyclic Hydroxyamidines as Amide Isosteres: Discovery of Oxadiazolines and Oxadiazines as Potent and Highly Efficacious γ-Secretase Modulators in VivoZ. J. Sun, Zhaoning Zhu, Thomas Bara et al.|Journal of Medicinal Chemistry|2011Cited by 53
Synthesis and SAR Studies of Fused Oxadiazines as γ-Secretase Modulators for Treatment of Alzheimer's DiseaseXianhai Huang, Alexei V. Buevich, Troy McCraken et al.|ACS Medicinal Chemistry Letters|2012Cited by 39